COVAXIN found SAFE in Phase 1 Trial; Phase 2 Trials in September
TNI Bureau: India's first indigenous Covid-19 Vaccine, "COVAXIN" - developed by Bharat Biotech-ICMR, has been found to be safe without any adverse impacts in the Phase 1 trial.
Phase 2 trials will begin in September. If all trials…